Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Guangzhou Wondfo Biotech C-A (300482 CH)
Watchlist
21
Analysis
Health Care
•
China
Guangzhou Wondfo Biotech Co.,Ltd. was founded in 1992. The company's line of business includes manufacturing of medical diagnostic tests. Guangzhou Wondfo Biotech serves customers around the world.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Zhejiang Orient Gene Biotech C
•
03 Dec 2023 09:29
China Healthcare Weekly (Dec.1) - Medical Device VBP, Biotech to Breakeven Soon, Orient Gene Biotech
VBP result for intraocular lens/sports medicine consumables is better than expected.There’s a chance to see Chinese Biotech turn loss into profits...
Xinyao (Criss) Wang
Follow
439 Views
Share
bullish
•
Western Superconducting Techno
•
11 Sep 2023 07:00
CSI500 Index Rebalance Preview: ETF Inflows Lead to Performance Skew
There should be 50 changes in Dec with a big sector skew. Turnover is ~10% and 31 stocks will have 1x ADV to trade. Huge ETF inflows have led to...
Brian Freitas
Follow
587 Views
Share
bullish
•
Guangzhou Wondfo Biotech C-A
•
05 Jul 2023 08:55
Guangzhou Wondfo Biotech (300482.CH) - Time to Bottom Fish?
Overall revenue growth would inevitably slow down in 2023, but Wondfo's non-COVID business recovered well in 23Q1, which shows us the momentum to...
Xinyao (Criss) Wang
Follow
330 Views
Share
bullish
•
Eoptolink Technology
•
04 Jul 2023 05:40
CSI500 Index Rebalance Preview: Potential Adds Outperforming Potential Deletes
We see 50 changes a side for the CSI500 in Dec. The Industrials sector could take a lot of index spots from Materials as one-way turnover exceeds...
Brian Freitas
Follow
496 Views
Share
bullish
•
TVS Motor
•
04 Jun 2023 05:55
Index Rebalance & ETF Flow Recap: CSI300/500, Chinext, China Semi Chips, Nifty Next50, SET50, REMX
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
611 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x